Skip to main content

Animations

MJFF Publications

5411 - 5420 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2019
  • 2018
  • 2024
  • 2023
  • 2024
  • 2016
  • 2020
  • 2025
  • 2022
  • Summary Details
    OPEN
    Title: Amygdala Neurodegeneration: A Key Driver of Visual Dysfunction in Parkinson's Disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.70007
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.027
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Consensus for the measurement of the camptocormia angle in the standing patient
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.013
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Understanding what aspects of Parkinson’s disease matter most to patients and families
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41598-024-71555-4
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.3c00437
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-024-03702-3
    Citation Count: 6
  • Summary Details
    OPEN
    Title: α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-016-0532-8
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Distribution of Parkinson’s disease associated RAB39B in mouse brain tissue
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-020-00584-7
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Seeding-competent early tau multimers are associated with cell type-specific transcriptional signatures
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-025-02869-4
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Novel lower-extremity dexterity assessment for Parkinson’s disease: validation against measures of arm dexterity and general mobility
    Journal Name: Disability and Rehabilitation
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/09638288.2021.2025273
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.